tiprankstipranks
Oncolytics Biotech (TSE:ONC)
TSX:ONC
Holding TSE:ONC?
Track your performance easily

Oncolytics Biotech (ONC) Financial Statements

193 Followers

Oncolytics Biotech Financial Overview

Oncolytics Biotech's market cap is currently ―. The company's EPS TTM is C$-0.364; its P/E ratio is -3.24; Oncolytics Biotech is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is C$-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -9.53MC$ -7.16MC$ -6.89MC$ -3.91MC$ -9.92M
EBITDAC$ -9.55MC$ -6.94MC$ -6.77MC$ -3.80MC$ -9.81M
Net Income Common StockholdersC$ -9.54MC$ -7.26MC$ -6.89MC$ -3.95MC$ -9.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 19.60MC$ 24.85MC$ 29.60MC$ 34.91MC$ 39.98M
Total AssetsC$ 24.26MC$ 32.07MC$ 34.75MC$ 38.82MC$ 46.09M
Total DebtC$ 1.06MC$ 1.12MC$ 1.13MC$ 423.00KC$ 514.00K
Net DebtC$ -18.53MC$ -23.73MC$ -28.48MC$ -34.49MC$ -39.47M
Total LiabilitiesC$ 15.21MC$ 13.76MC$ 11.78MC$ 11.26MC$ 17.07M
Stockholders EquityC$ 9.06MC$ 18.31MC$ 22.97MC$ 27.56MC$ 29.02M
Cash Flow-
Free Cash FlowC$ 2.65MC$ -14.49MC$ -7.51MC$ -6.13MC$ -6.03M
Operating Cash FlowC$ 2.64MC$ -14.29MC$ -7.47MC$ -6.12MC$ -6.03M
Investing Cash FlowC$ 14.00KC$ -201.00KC$ -46.00KC$ -3.00KC$ 6.77M
Financing Cash FlowC$ -1.67MC$ 3.47MC$ 1.50MC$ 1.74MC$ 21.29M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History

Oncolytics Biotech Debt to Assets

Oncolytics Biotech Cash Flow

Oncolytics Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis